State Street’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

State Street’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-835,909	Closed	-$38.8M	–	4689
2023 Q2	$38.8M	Buy	835,909 +37,625	+5%	+$1.3M	﹤0.01%	1819
2023 Q1	$22.9M	Buy	798,284 +4,332	+0.5%	+$128K	﹤0.01%	2134
2022 Q4	$24.8M	Buy	793,952 +299,623	+61%	+$9.8M	﹤0.01%	2089
2022 Q3	$10M	Buy	494,329 +74,106	+18%	+$1.35M	﹤0.01%	2710
2022 Q2	$6.52M	Buy	420,223 +194,283	+86%	+$3.34M	﹤0.01%	2960
2022 Q1	$4.32M	Buy	225,940 +38,446	+21%	+$686K	﹤0.01%	3256
2021 Q4	$4.74M	Buy	+187,494	New	+$5.49M	﹤0.01%	3267

State Street's DICE Position: Q3 2023 in Review

State Street sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 835,909 shares — an estimated $38.8M sold.

State Street first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $38.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

State Street reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
State Street sold 835,909 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $38.8M.
State Street first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
State Street's DICE Therapeutics, Inc. Common Stock position peaked at $38.8M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.